Immunohistochemistry (IHC) confirmed DLBCL with diffuse CD20 and CD79a positivity, BCL2 (80%), BCL6 (40%), MUM1 (80%), and a high Ki67 index (up to 70%). This evidence concerns the gene BCL2 and diffuse large B-cell lymphoma.